Guided Therapeutics (GTHP) Debt Ratio (2010 - 2026)
Guided Therapeutics (GTHP) posted Debt Ratio of 0.02 for Q4 2025, down 45.91% sequentially from 0.03 in Q3 2025, and down 49.07% YoY from 0.03 in Q4 2024.
Guided Therapeutics (GTHP) Debt Ratio (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Debt Ratio for 16 years, with the latest figure at 0.02 in Q4 2025.
- Quarterly Debt Ratio fell 49.07% year-over-year to 0.02 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02 (down 49.07% YoY) and the FY2025 annual result came in at 0.02, down 49.07% from the prior year.
- Debt Ratio declined to 0.02 in Q4 2025 per GTHP's latest filing, from 0.03 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.95 in Q2 2024 and troughed at 0.01 in Q1 2023.
- A 5-year average of 0.22 and a median of 0.05 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio surged 1788.24% in 2024, then plunged 96.61% in 2025.
- Over 5 years, Debt Ratio stood at 0.33 in 2021, then plunged by 93.44% to 0.02 in 2022, then soared by 129.5% to 0.05 in 2023, then slumped by 32.0% to 0.03 in 2024, then plunged by 49.07% to 0.02 in 2025.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.02, 0.03, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.72 Bn | 196.12 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 126.49 Bn | 123.01 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 119.21 Bn | 109.99 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.88 Bn | 73.35 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.71 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.81 Bn | 32.86 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.29 Bn | 22.97 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn | 0.18 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.04 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.95 |
| Jun 30, 2024 | 0.95 |
| Mar 31, 2024 | 0.02 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.46 |
| Jun 30, 2021 | 0.43 |
| Mar 31, 2021 | 0.26 |